Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 20, 2024 8:00am
New Press Release - Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025
LONDON, Ontario and BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch bio-hybrid organ as a functional cure for type 1 diabetes, today announced that it will hold its...
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Dec 19, 2024 6:23am
Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour
The TSX has experienced a rocky week, marked by five consecutive sessions of declines, but several stocks offer compelling opportunities.
read article.
(127)
•••
bbowles
X
View Profile
View Bullboard History
Post by
bbowles
on Dec 12, 2024 1:10pm
REMINDER TO ATTEND
Town Hall for investors on Friday, December 13, at 10:00am ET.
(8)
•••
hoffbag
X
View Profile
View Bullboard History
Post by
hoffbag
on Dec 03, 2024 3:19pm
Saudi’s starting to buy
How far is this going to run ?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 02, 2024 8:00am
New Press Release - Sernova Update on Strategic Initiatives
Signed Letter of Intent with ‘Project REEM Ventures’ for Product Development and Commercialization in the Kingdom of Saudi ArabiaRenowned Diabetes Expert Dr. Robert Gabbay to Serve as Clinical AdvisorTown Hall Call to be Held on December 13; AGM Circular Available on December 6LONDON, Ontario and...
read article.
(425)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Dec 02, 2024 7:52am
Gone
Gone from strong to moderate buy. I guess the next one is a hold...really meaning don't buy. gl
(425)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Nov 27, 2024 4:42pm
another conference.
That should embolden some new investors.
(425)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Nov 24, 2024 9:22am
RE:Looks to me
Diluted,,,jeez
(425)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Nov 24, 2024 9:21am
Looks to me
Like this is becoming so heavily deluted that maybe the sometimes lofty share price predictions have factored in a post consolidation price. Dr. Witkowski's reports don't seem to have the
...more
(7)
•••
edrose
X
View Profile
View Bullboard History
Post by
edrose
on Nov 15, 2024 7:01am
loooking at this company it's been taking them years
to enroll patients and it takes years to get data to get fda or hpb in canada to see if they would approve this treatment which would help thousands of type 1 diabetics
(5)
•••
palladium17
X
View Profile
View Bullboard History
Comment by
palladium17
on Nov 09, 2024 2:33pm
RE:RE:RE:this board
RixPix you are right it is very little.
(180)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Nov 01, 2024 7:45am
RE:RE:this board
Half a million shares shorted is nothing for SVA. A Private Placement was done 2 months ago so having some shares shorted is nothing important. GL.
(180)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Nov 01, 2024 7:40am
RE:this board
Hey WK. They've moved on, but not because they sold. They're all on another site. CEO . Ca. Bioteck signed up as RixPix before I went there and I'm there too now.
(127)
•••
bbowles
X
View Profile
View Bullboard History
Comment by
bbowles
on Oct 29, 2024 12:03pm
RE:this board
Yep everyone has left this submarine except for the shorts. Number of Shares Shorted Net Change Oct 15, 2024 593,320 175,757
(425)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Oct 29, 2024 9:09am
this board
This board is no fun. Where did all the posters go from a couple of years ago? You know, the ones critisizing "spillup". Obviously they have sold and moved on. This is my second go around
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 11, 2024 7:32am
New Press Release - Sernova Announces Key New Executive Appointments
(TheNewswire) Experienced leadership team positions company to advance Cell Pouch™ bio-hybrid organ programs. LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – October 11, 2024 – Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company currently...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.